Research advances in breast milk-acquired cytomegalovirus infection in premature infants

RAN Li-Hong; BAO Lei

doi:10.7499/j.issn.1008-8830.2016.10.003

PDF(1138 KB)

Chinese Journal of Contemporary Pediatrics ›› 2016, Vol. 18 ›› Issue (10) : 931-936. DOI: 10.7499/j.issn.1008-8830.2016.10.003

TOPIC OF BREASTFEEDING

Research advances in breast milk-acquired cytomegalovirus infection in premature infants

RAN Li-Hong, BAO Lei

Author information +

History +

Abstract

Breast milk is considered ideal food for premature infants, but it can also be the main source of cytomegalovirus (CMV) infection in premature infants. CMV infection may cause serious clinical symptoms, such as sepsis-like syndrome, thrombocytopenia, neutropenia, jaundice, hepatitis, and pneumonitis. This article reviews the research advances in symptoms, treatment strategies, prognosis and the prevention of breast milk-acquired CMV infection in premature infants

Key words

Acquired cytomegalovirus infection / Breast milk / Premature infant

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

RAN Li-Hong, BAO Lei. Research advances in breast milk-acquired cytomegalovirus infection in premature infants[J]. Chinese Journal of Contemporary Pediatrics. 2016, 18(10): 931-936 https://doi.org/10.7499/j.issn.1008-8830.2016.10.003

References

[1] 姜燕飞, 戴智勇, 李勇. 早产儿母乳喂养对其生理、营养和临床表现的影响[J]. 中国生育健康杂志, 2015, 26(4): 379-382.
[2] Carling S, Demment MM, Kjolhede CL, et al. Breastfeeding duration and weight gain trajectory in infancy[J]. Pediatrics, 2015, 135(1): 111-119.
[3] Yamakawa M, Yorifuji T, Inoue S, et al. Breastfeeding and obesity among schoolchildren: a nationwide longitudinal survey in Japan[J]. JAMA Pediatr, 2013, 167(10): 919-925.
[4] Bergström A, Skov TH, Bahl MI, et al. Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants[J]. Appl Environ Microbiol, 2014, 80(9): 2889-2900.
[5] Underwood MA, Gaerlan S, De Leoz ML, et al. Human milk oligosaccharides in premature infants: absorption, excretion, and influence on the intestinal microbiota[J]. Pediatr Res, 2015, 78(6): 670-677.
[6] Zhou J, Shukla VV, John D, et al. Human milk feeding as a protective factor for retinopathy of prematurity: a metaanalysis[ J]. Pediatrics, 2015, 136(6): e1576-e1586.
[7] Josephson CD, Caliendo AM, Easley KA, et al. Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: a prospective cohort study[J]. JAMA Pediatr, 2014, 168(11): 1054-1062.
[8] 汪德海, 高楠, 于磊. 献血人群人巨细胞病毒检验筛查策略的建立[J]. 北京医学, 2015, 37(8): 801-803.
[9] Álvarez Domínguez E, Figueras Aloy J, Botet Mussons F, et al. Screening for cytomegalovirus infection in very low birth weight infants[J]. An Pediatr (Barc), 2013, 79(1): 3-9.
[10] 裴蕴锋. 小儿巨细胞病毒感染状况分析[J]. 检验医学与临床杂志, 2013, 10(8): 980-981.
[11] 北京地区母婴巨细胞病毒感染调查协作组. 北京地区母婴巨细胞病毒感染状况调查[J]. 中华围产医学杂志, 2012, 15(8): 459-461.
[12] 润袁敏, 管建, 徐春芬. 武汉地区儿童感染巨细胞病毒状况[J]. 广东医学杂志, 2013, 34(18): 2849-2851.
[13] Kurath S, Halwachs-Baumann G, Müller W, et al. Transmission of cytomegalovirus via breast milk to the prematurely born infant: a systematic review[J]. Clin Microbiol Infect, 2010, 16(8): 1172-1178.
[14] Arellano-Galindo J, Villanueva-García D, Cruz-Ramirez JL, et al. Detection and gB genotyping of CMV in Mexican preterm infants in the context of maternal seropositivity[J]. J Infect Dev Ctries, 2014, 8(6): 758-767.
[15] Ehlinger EP, Webster EM, Kang HH, et al. Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants[J]. J Infect Dis, 2011, 204(11): 1672-1682.
[16] Gunkel J, Wolfs TF, de Vries LS, et al. Predictors of severity for postnatal cytomegalovirus infection in preterm infants and implications for treatment[J]. Expert Rev Anti Infect Ther, 2014, 12(11): 1345-1355.
[17] Kurath S, Halwachs-Baumann G, Müller W, et al. Transmission of cytomegalovirus via breast milk to the prematurely born infant: a systematic review[J]. Clin Microbiol Infect, 2010, 16(8): 1172-1178.
[18] Alarcón Allen A, Baquero-Artigao F; Grupo de estudio de la infección por citomegalovirus de la Sociedad Española de Infectología Pediátrica. Review and guidelines on the prevention, diagnosis and treatment of post-natal cytomegalovirus infection[J]. An Pediatr (Barc), 2011, 74(1): 52.e1-52.e13.
[19] Nijman J, de Vries LS, Koopman-Esseboom C, et al. Postnatally acquired cytomegalovirus infection in preterm infants: a prospective study on risk factors and cranial ultrasound findings[J]. Arch Dis Child Fetal Neonatal Ed, 2012, 97(4): 259-263.
[20] Mehler K, Oberthuer A, Lang-Roth R, et al. High rate of symptomatic cytomegalovirus infection in extremely low gestational age preterm infants of 22-24 weeks' gestation after transmission via breast milk[J]. Neonatology, 2014, 105(1): 27-32.
[21] Tengsupakul S, Birge ND, Bendel CM, et al. Asymptomatic DNAemia heralds CMV-associated NEC: case report, review, and rationale for preemption[J]. Pediatrics, 2013, 132(5): e1428-e1434.
[22] Takahashi R, Tagawa M, Sanjo M, et al. Severe postnatal cytomegalovirus infection in a very premature infant[J]. Neonatology, 2007, 92(4): 236-239.
[23] Neuberger P, Hamprecht K, Vochem M, et al. Case-control study of symptoms and neonatal outcome of human milk-transmitted cytomegalovirus infection in premature infants[J]. J Pediatr, 2006, 148(3): 326-331.
[24] Kimberlin DW, Jester PM, Sánchez PJ, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease[J]. N Engl J Med, 2015, 372(10): 933-943.
[25] Jim WT, Chiu NC, Ho CS, et al. Outcome of preterm infants with postnatal cytomegalovirus infection via breast milk: a twoyear prospective follow-up study[J]. Medicine (Baltimore), 2015, 94(43): e1835.
[26] Goelz R, Meisner C, Bevot A, et al. Long-term cognitive and neurological outcome of preterm infants with postnatally acquired CMV infection through breast milk[J]. Arch Dis Child Fetal Neonatal Ed, 2013, 98(5): 430-433.
[27] Yoo HS, Sung SI, Jung YJ, et al. Prevention of cytomegalovirus transmission via breast milk in extremely low birth weight infants[J]. Yonsei Med J, 2015, 56(4): 998-1006.
[28] Lanzieri TM, Dollard SC, Josephson CD, et al. Breast milkacquired cytomegalovirus infection and disease in VLBW and premature infants[J]. Pediatrics, 2013, 131(6): 1937-1945.
[29] Chiavarini M, Bragetti P, Sensini A. Breastfeeding and transmission of cytomegalovirus to preterm infants. Case report and kinetic of CMV-DNA in breast milk[J]. Ital J Pediatr, 2011, 37: 6.
[30] Hayashi S, Kimura H, Oshiro M, et al. Transmission of cytomegalovirus via breast milk in extremely premature infants[J]. J Perinatol, 2011, 31(6): 440-445.
[31] Omarsdottir S, Casper C, Navér L, et al. Cytomegalovirus infection and neonatal outcome in extremely preterm infants after freezing of maternal milk[J]. Pediatr Infect Dis J, 2015, 34(5): 482-489.
[32] Gomes FP, Shaw PN, Whitfield K, et al. Effect of pasteurisation on the concentrations of vitamin D compounds in donor breastmilk[J]. Int J Food Sci Nutr, 2016, 67(1): 16-19.
[33] 李淑娟, 曹云. 早产儿经母乳获得性巨细胞病毒感染的研究进展[J]. 中华围产医学杂志, 2014, 17(11): 773-777.
[34] Meier PP, Engstrom JL, Patel AL, et al. Improving the use of human milk during and after the NICU stay[J]. Clin Perinatol, 2010, 73(1): 217-245.
[35] Dempsey AF, Pangborn HM, Prosser LA. Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus[J]. Vaccine, 2012, 30(27): 4060-4066.
[36] Nigro G, Capretti I, Manganello AM, et al. Primary maternal cytomegalovirus infections during pregnancy: association of CMV hyperimmune globulin with gestational age at birth and birth weight[J]. J Matern Fetal Neonatal Med, 2015, 28(2): 168-171.
[37] Revello MG, Lazzarotto T, Guerra B, et al. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus[J]. N Engl J Med, 2014, 370(14): 1316-1326.